EURETINA: Bayer discusses relevant clinical study results

Описание к видео EURETINA: Bayer discusses relevant clinical study results

Patrick Bussfeld, MD, VP, head medical affairs ophthalmology at Bayer Consumer Care AG, discusses the results from several treat-and-extend studies on aflibercept, and how Bayer is participating in the 2020 EURETINA virtual meeting.

Комментарии

Информация по комментариям в разработке